Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Xueyan Chen

1PUBLICATIONS

10CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 22, 2022

Tumor-derived OBP2A promotes prostate cancer castration resistance.

Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li

Pageof 1

Frequent Collaborators

1 joint publications

Ji-Hak Jeong

1 joint publications

Shangwei Zhong

1 joint publications

Fuzhuo Li

1 joint publications

Changhao Huang

1 joint publications

Qingqing Liu

1 joint publications

Shoujiao Peng

1 joint publications

HaJeung Park

1 joint publications

You Mie Lee

1 joint publications

Jasreman Dhillon

1 joint publications

Jun-Li Luo

Frequent Collaborators

1 joint publications

Ji-Hak Jeong

1 joint publications

Shangwei Zhong

1 joint publications

Fuzhuo Li

1 joint publications

Changhao Huang

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

See more related videos

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

See more related videos